Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study Simona LattanziFederica Ranzatoon behalf of the BLESS Study Group ORIGINAL RESEARCH Open access 08 June 2024
Old and New Strategies in the Treatment of Pediatric Multiple Sclerosis: A Personal View for a New Treatment Approach Angelo Ghezzi COMMENTARY Open access 01 June 2024
Photophobia and Visual Triggers in Vestibular Migraine Xiaodong ZouJiahui HeLiang Guo ORIGINAL RESEARCH Open access 31 May 2024
Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc Analysis Gilbert J. L’ItalienEvangelos K. OikonomouVladimir Coric BRIEF REPORT Open access 30 May 2024
Risk Factors and Clinical Significance of Ultra-Long-Term Microischemia After Intracranial Aneurysm Embolization Yi SongJianxin ZhouYuan Cheng ORIGINAL RESEARCH Open access 30 May 2024
The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson’s Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On Pekka T. MännistöTapani KeränenPiero Pollesello REVIEW Open access 29 May 2024
Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO® in Healthy Adults Olivier LacombeYannick PletanOlivier Giré ORIGINAL RESEARCH Open access 28 May 2024
Letter to the Editor regarding: “Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary” by R. Rosenberg et al Thomas Roth LETTER Open access 25 May 2024
Response to Letter to the Editor Regarding “Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients With Narcolepsy: A Commentary” Chad RuoffShawn CandlerJed Black LETTER Open access 25 May 2024
Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial Marc MoulinDavid C. CrowleyErin D. Lewis ORIGINAL RESEARCH Open access 17 May 2024
Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals Ardra ShephardLaura KolaczkowskiGavin Giovannoni REVIEW Open access 17 May 2024
Male Reproduction in Spinal Muscular Atrophy (SMA) and the Potential Impact of Oral Survival of Motor Neuron 2 (SMN2) Pre-mRNA Splicing Modifiers Natan Bar-ChamaBakri ElsheikhLutz Mueller COMMENTARY Open access 16 May 2024
Sustained Effectiveness and Safety Over Time of Teriflunomide in Chinese Patients with Relapsing Multiple Sclerosis in the Greater Bay Area of China: Insights from Real-World Data Rui LiJing ZhouJuanjuan Chen ORIGINAL RESEARCH Open access 16 May 2024
Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder Valerie ArnoldSonia Ancoli-IsraelMargaret Moline ORIGINAL RESEARCH Open access 15 May 2024
Myasthenia Gravis Disease Burden and Its Impact on Satisfaction with Life: A Qualitative Survey of Patients’ Perspectives in Japan Naoki KawaguchiKoichi TsudaDaisuke Harada ORIGINAL RESEARCH Open access 15 May 2024
Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review Elise E. DunningBoris DecourtMarwan N. Sabbagh REVIEW Open access 14 May 2024
Fake Xanax: Designer Emerging Benzodiazepine Epidemic Linked to Morbidity and Mortality a Narrative Review Alan D. KayeJoseph P. TassinAmber N. Edinoff REVIEW Open access 10 May 2024
Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant Recipients Velina Nedkova-HristovaLaura DonadeuCarlos Casasnovas ORIGINAL RESEARCH Open access 10 May 2024
Additional Results from Two Randomized, Placebo-Controlled Trials of Stiripentol in Dravet Syndrome Highlight a Rapid Antiseizure Efficacy with Longer Seizure-Free Periods Renzo GuerriniLaurent ChancharmeCatherine Chiron ORIGINAL RESEARCH Open access 09 May 2024 Pages: 869 - 884
Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder Stacey L. ClardySean J. PittockIna Zhang REVIEW Open access 09 May 2024 Pages: 535 - 549
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians Kathryn A. Wyman-ChickParichita ChaudhuryJoseph P. M. Kane PRACTICAL APPROACH Open access 08 May 2024 Pages: 885 - 906
Unsupervised Machine Learning Revealed that Repeat Transcranial Magnetic Stimulation is More Suitable for Stroke Patients with Statin Chaohua CuiChanghong LiTianyu Xia ORIGINAL RESEARCH Open access 30 April 2024 Pages: 857 - 868
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study Adam StrzelczykMarta MaschioVicente Villanueva ORIGINAL RESEARCH Open access 28 April 2024 Pages: 825 - 855
Epidemiology, Patient Characteristics, and Treatment Patterns of Myasthenia Gravis in Taiwan: A Population-Based Study Nai-Wen TsaiLi-Nien ChienJiann-Horng Yeh ORIGINAL RESEARCH Open access 27 April 2024 Pages: 809 - 824
Dental Adverse Effects of Anti-CD20 Therapies Hélène BartakTasnim FarehChristine Lebrun-Frenay CASE SERIES Open access 26 April 2024 Pages: 917 - 930
Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations Anne Marie MorseRichard K. BoganMichael J. Thorpy ORIGINAL RESEARCH Open access 25 April 2024 Pages: 785 - 807
A Retrospective Analysis of Central and Peripheral Metabolic Characteristics in Patients with Cryptococcal Meningitis Jianglong QinLanwei NongSijun Li ORIGINAL RESEARCH Open access 20 April 2024 Pages: 763 - 784
Group-Based Trajectory Modeling of Fluid Balance in Elderly Patients with Acute Ischemic Stroke: Analysis from Multicenter ICUs Jia TangChangdong WuZhenguang Zhong ORIGINAL RESEARCH Open access 18 April 2024 Pages: 749 - 761
Chinese Translation and Validation of the Center for Neurologic Study Lability Scale Lu ChenShan YeDongsheng Fan ORIGINAL RESEARCH Open access 16 April 2024 Pages: 739 - 747
Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study Xiao ZhangXinzhi HuTao Wang ORIGINAL RESEARCH Open access 15 April 2024 Pages: 727 - 737
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study Xiao-Na MaWei FengQiang Xu ORIGINAL RESEARCH Open access 09 April 2024 Pages: 715 - 725
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis Jerome de SezeDominique DiveChiara Zecca REVIEW Open access 08 April 2024 Pages: 519 - 533
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study Takao TakeshimaHikaru DoiMika Komori ORIGINAL RESEARCH Open access 06 April 2024 Pages: 697 - 714
Donanemab in Japanese Patients with Early Alzheimer’s Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial Shoichiro SatoNaohisa HatakeyamaJohn R. Sims ORIGINAL RESEARCH Open access 06 April 2024 Pages: 677 - 695
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease Samuel FrankKaren E. AndersonMaria Chen ORIGINAL RESEARCH Open access 01 April 2024 Pages: 655 - 675
Anti-N-methyl-d-aspartate Receptor Encephalitis in People Living with HIV: Case Report and Literature Review Jiangjin HuiJinhua WangBiao Zhu CASE SERIES Open access 26 March 2024 Pages: 907 - 916
REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program Matthias SchwabAndrew ChanChristoph Grothe ORIGINAL RESEARCH Open access 26 March 2024 Pages: 641 - 653
Impact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study Marco LuigettiDianna QuanDavid Adams ORIGINAL RESEARCH Open access 21 March 2024 Pages: 625 - 639
Publisher Correction: Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation Sarah A. MorrowPaola KrugerNektaria Alexandri Publisher Correction Open access 19 March 2024 Pages: 501 - 501
Correction: Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment Angelo GhezziR. F. Neuteboom Correction Open access 18 March 2024 Pages: 931 - 931
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France Jonathan CironBertrand BourrePatrick Vermersch REVIEW Open access 15 March 2024 Pages: 503 - 518
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study Piero BarbantiGabriella Egeofor the Italian Migraine Registry study group ORIGINAL RESEARCH Open access 07 March 2024 Pages: 611 - 624
Impact of Immune Cells on Stroke Limited to Specific Subtypes: Evidence from Mendelian Randomization Study Chen ChenQi LiuLi Liu ORIGINAL RESEARCH Open access 06 March 2024 Pages: 599 - 609
Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey Mary A. CurryRosángel E. CruzJill Jarecki ORIGINAL RESEARCH Open access 02 March 2024 Pages: 583 - 598
The Association Between National Institutes of Health Stroke Scale Score and Clinical Outcome in Patients with Large Core Infarctions Undergoing Endovascular Treatment Lingyu ZhangJinfu MaPengfei Wang ORIGINAL RESEARCH Open access 01 March 2024 Pages: 563 - 581
Constructing and Validating a Nomogram Model for Short-Term Prognosis of Patients with AChR-Ab+ GMG Feng LiangZhaoxu YinWei Zhang ORIGINAL RESEARCH Open access 01 March 2024 Pages: 551 - 562
Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation Sarah A. MorrowPaola KrugerNektaria Alexandri SUMMARY OF RESEARCH Open access 20 February 2024 Pages: 497 - 499
Monitoring of Perioperative Microcirculation Dysfunction by Near-Infrared Spectroscopy for Neurological Deterioration and Prognosis of Aneurysmal Subarachnoid Hemorrhage: An Observational, Longitudinal Cohort Study Shunyan YangBinbin TanLihua Wang ORIGINAL RESEARCH Open access 17 February 2024 Pages: 475 - 495
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study Taoufik AlsaadiReem SulimanYazan Bader ORIGINAL RESEARCH Open access 15 February 2024 Pages: 465 - 473
Understanding the Symptoms and Impacts Experienced by People with Relapsing–Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews Amy BarrettOyebimpe Olayinka-AmaoPaul Kamudoni ORIGINAL RESEARCH Open access 12 February 2024 Pages: 449 - 464
